From 5-Azapyrimidine Chemistry to Thiadiazoles
Author(s) -
Marcela Krečmerová
Publication year - 2022
Publication title -
chemické listy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.137
H-Index - 28
eISSN - 1213-7103
pISSN - 0009-2770
DOI - 10.54779/chl20220152
Subject(s) - chemistry , decitabine , prodrug , moiety , nucleophile , thiadiazoles , stereochemistry , cytosine , dna , nucleobase , nucleoside , nucleic acid , combinatorial chemistry , biochemistry , dna methylation , gene , organic chemistry , gene expression , catalysis
The review is devoted to 5-aza- and 6-azapyrimidine nucleosides with emphasis on antileukemic agents 5‑azacytidine and 2′-deoxy-5-azacytidine (decitabine), mechanism of their action as inhibitors of DNA methylations in tumour suppressor genes and current trends in the search for their stabilized analogues. A significant contribution to 5-azacytosine chemistry is synthesis of 5-azacytosine acyclic nucleosides phosphonates and their prodrugs, identified as potent and selective anti-DNA viral agents. Application of 5-amino-1,2,4-thiadiazol-3-(2H)-one moiety to acyclic nucleoside analogues was inspired by hypothesis that this heterocyclic base could work as a cytosine mimic and, moreover, the reactive N-S bond could be able to attack strong nucleophiles such as the cysteine thiol group of enzymes (similarly as 5‑azacytosine). A series of prepared 1,2,4-thiadiazole derivatives provided several inhibitors of Cathepsin K and glycogen synthase kinase 3β effective in the low micromolar range.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom